PT  - JOURNAL ARTICLE
AU  - Buckley, Rita
ED  - Yki-Järvinen, Hannele
TI  - Linagliptin Proves Safe and Effective as Add-on Therapy to Basal Insulin
DP  - 2012 Dec 01
TA  - MD Conference Express
PG  - 15--16
VI  - 12
IP  - 16
4099  - http://mdc.sagepub.com/content/12/16/15.short
4100  - http://mdc.sagepub.com/content/12/16/15.full
AB  - Linagliptin may be a treatment option in patients with type 2 diabetes mellitus (T2DM) taking basal insulin, especially in those prone to hypoglycemia and/or declining renal function, according to results from a 52-week, multicenter, randomized, placebo-controlled, Phase 3 clinical trial.